atherogenesis

(redirected from atherogenicity)
Also found in: Dictionary, Medical.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to atherogenesis

the formation of atheromas on the walls of the arteries as in atherosclerosis

Related Words

References in periodicals archive ?
The thrombogenicity index and atherogenicity index were proposed by Ulbricht and Southgate (1991) with the aim of considering not only the family of fatty acids but also their biological effect.
The potential pharmacological actions of herbs or isolates are not limited to inhibiting SMC phenotypic switch, but they can also improve other pro-atherogenic parameters such as endothelial dysfunction, platelet activation, lipid peroxidation, pro-inflammatory signaling, ROS production and macrophage atherogenicity.
The ability of blood serum to induce cholesterol accumulation is referred to as serum atherogenicity.
Zilmer, "Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects," British Journal of Nutrition, vol.
The nutritional quality index is estimated by several indices of fatty acid composition; the indices of atherogenicity (IA) and thrombogenicity (IT), according to Turan and coworkers [42], the hypocholesterolemic/hypercholesterolemic fatty acid ratio (HH) according to Testi and coworkers [40], EPA + DHA, PUFA/(SFA-stearic acid) according to Unusan [44], PUFA/SFA ratio according to Kalogeropoulos et al.
These indices were available for atherogenicity (IA) = [(12:0 + (4 x 14:0) + 16:0)] / (MUFA + n-6 + n-3), and thrombogenicity (IT) = (14:0 + 16:0 + 18:0) / [(0.
Such an aggregation of Lp(a) to apoA-I or another protective protein may modulate the apoA-I particles, elevated in concentrations and pro-inflammatory, ultimately leading to diabetogenicity (1,4) and atherogenicity (2), documented in Turks.
Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats.
Modulation of lipoprotein(a) atherogenicity by high density lipoprotein cholesterol levels in middle-aged men with symptomatic coronary artery disease and normal to moderately elevated serum cholesterol.
Coefficient of atherogenicity decreased non significantly (p<0,07) from 3,86[+ or -]0,14 to 3,04[+ or -]0,16.
Genest and Cohn posit that the challenge for future epidemiological studies will be to better define the link between CAD and a) the level of particular lipoprotein subfractions, b) factors affecting lipoprotein metabolism, and c) factors affecting the atherogenicity of plasma lipoproteins.
In studying the lipid profile content were determined: total cholesterol, triglycerides, HDL cholesterol, LDL and VLDL cholesterol very low density, coefficient of atherogenicity.
Cultures of smooth muscle cells from human aorta were used as a testing model for evaluation of serum atherogenicity and effectiveness of anti-atherogenic drugs and food components.